drugset / Trial / NCT02295150
Prophylaxis of Venous Thromboembolism After Bariatric Surgery
NaSingle-groupOpen-labelPrevention
Summary
This study is a prospective evaluation of the relationship between lean body weight and anti-Xa activity and 5700 International Units (IU) nadroparin 4 hours after subcutaneous administration in morbidly obese patients after bariatric surgery.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nadroparin Calcium | Other / unclassified | 5700 iu | Subcutaneous |